Bone marrow mesenchymal stem cells inhibit hepatic fibrosis via the AABR07028795.2/rno-miR-667-5p axis

BACKGROUND: The mechanism of bone marrow mesenchymal stem cells (BMSCs) in treating hepatic fibrosis remains unclear. METHODS: TGF-β1-induced hepatic stellate cell (HSC)-T6 and CCl4-induced hepatic fibrosis rats were treated with BMSCs. HSC-T6 cell activity was determined using the cell counting kit...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yuan, Li, Yanjie, Xu, Mingxing, Meng, Hongyu, Dai, Cao, Yao, Zhicheng, Lin, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331515/
https://www.ncbi.nlm.nih.gov/pubmed/35902883
http://dx.doi.org/10.1186/s13287-022-03069-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331515/
https://www.ncbi.nlm.nih.gov/pubmed/35902883
http://dx.doi.org/10.1186/s13287-022-03069-7

Ejemplares similares